ertapenem has been researched along with Cronobacter Infections in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (17.07) | 29.6817 |
2010's | 61 (74.39) | 24.3611 |
2020's | 7 (8.54) | 2.80 |
Authors | Studies |
---|---|
Bille, J; Lartigue, MF; Nordmann, P; Poirel, L; Wenger, A; Zinsius, C | 1 |
André, C; Arpin, C; Coulange, L; Couture, JF; Doermann, HP; Dubois, V; Ducastaing, A; Dutilh, B; Fischer, I; Fourmaux, S; Grobost, F; Jullin, J; Lagrange, I; Noury, P; Quentin, C | 1 |
Castanheira, M; Deshpande, LM; Fritsche, TR; Jones, RN; Sader, HS | 1 |
Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F | 1 |
Akan, OA; Carrër, A; Cuzon, G; Feriha, C; Honderlick, P; Matar, G; Nordmann, P; Poirel, L; Yilmaz, M | 1 |
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY | 1 |
Bernabeu, S; Berthelot, P; Carricajo, A; Nordmann, P; Poirel, L; Pozzetto, B; Ros, A | 1 |
Alegría, Y; Cruz, R; López, E; Meneses, C | 1 |
Byun, JH; Chong, Y; Gim, JL; Lee, K; Yong, D; Yum, JH | 1 |
Buchs, N; Carevic, B; Carmeli, Y; Cohen-Percia, S; Dubinsky-Pertzov, B; Fallach, N; Fankhauser-Rodriguez, C; Harbarth, S; Kariv, Y; Klausner, J; Nutman, A; Radovanovic, I; Ris, F; Schiffer, E; Temkin, E | 1 |
Hsueh, PR; Jean, SS | 2 |
Bonnet, F; Bourdel Marchasson, I; Breilh, D; Cazanave, C; Cressot, V; de Thezy, A; Durrieu, J; Foucaud, C; Greib, C; Guerville, F; Kobeh, D; Lafargue, A; Legeron, R; Moneger, N; Ollivier, J; Pinganaud, G; Roubaud Baudron, C; Thiel, E; Videau, MN | 1 |
Abe, R; Akeda, Y; Hagiya, H; Hamada, S; Ishii, Y; Nishi, I; Sakamoto, N; Shanmugakani, RK; Sugawara, Y; Takeuchi, D; Tomono, K; Tsutsumi, Y; Yamamoto, N | 1 |
Carevic, B; Carmeli, Y; Cohen-Percia, S; Fallach, N; Frenk, S; Harbarth, S; Hoffman, T; Kariv, Y; Klausner, J; Lellouche, J; Nutman, A; Temkin, E | 1 |
Cady, KC; Chan, R; Chu, K; Eckert, B; Goldman, D; Hanson, B; Lam, CN; Lin, PH; Martins-Sorenson, N; Mehta-Kolte, MG; Moghaddasi, A; Nguyen, H; Nukala, L; Suko, S; Yuan, R | 1 |
Abraham, M; Delate, T; Hudson, E; Nguyen, JK; Wong, CP; Yang, SJ | 1 |
Allerberger, F; Jesumirhewe, C; Lepuschitz, S; Ruppitsch, W; Springer, B | 1 |
Darling, LA; Evans, AM; Montero, CI; Nattanmai, SM; Stellrecht, KA | 1 |
Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y | 1 |
Perez, LRR | 1 |
Abdul, W; Grigoriu, A; Smoke, SM; Vasant, D | 1 |
Hackel, MA; Hoban, DJ; Lob, SH; Motyl, MR; Sahm, DF; Young, K | 1 |
Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W | 1 |
Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N | 1 |
Mythreyee, M; Sekar, R; Srivani, S | 1 |
Blanco, VM; Camargo, RD; Correa, A; Cuesta, DP; Florez, E; Hernández-Gómez, C; Matta, L; Maya, JJ; Motoa, G; Muñoz, M; Nagles, J; Ovalle, A; Reyes, S; Rosso, F; Vallejo, ME; Villegas, MV | 1 |
Bazan, JA; Coe, KE; Elefritz, JL; Fussner, LA; Holsen, MR; Wardlow, LC | 1 |
Bodro, M; Bosch, J; Cervera, C; Cofán, F; Dieckmann, F; Linares, L; Marco, F; Moreno, A; Oppenheimer, F; Sanclemente, G | 1 |
Knezevic, NN; Tinevez, D | 1 |
Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ | 2 |
Borges, JV; Fonseca, ME; Jaskulski, MR; Machado, DC; Marinowic, DR; Medeiros, BC; Nodari, P; Rocha, MP; Zalewsky, R | 1 |
Chang, CL; Chang, KK; Huang, YC; Lu, CM; Su, LH; Tai, FT | 1 |
Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE | 1 |
Chan, KW; Huang, YC; Kao, CC; Lin, CF; Liu, JW; Liu, PY; Shi, ZY; Shyu, CL; Tung, KC; Wu, ZY | 1 |
Barth, AL; da Silva, RC; Dalarosa, MG; Falci, DR; Luz, DI; Magagnin, CM; Ribeiro, VB; Rozales, FP; Sampaio, JM; Vieira, FJ; Zavascki, AP | 1 |
Ahn, C; Doi, Y; Hu, F; O'Hara, JA; Rivera, JI; Syed, A | 1 |
Blanchette, LM; Kuti, JL; Nailor, MD; Nicolau, DP | 1 |
Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
Daitch, V; Farbman, L; Lador, A; Leibovici, L; Paul, M; Tredler, Z; Zusman, O | 1 |
Chung, HS; Lee, M | 1 |
Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K | 1 |
Cattoir, V; Derdouri, S; Dupont, H; Emond, JP; Gaillard, N; Gaillot, O; Girard de Courtilles, M; Goetgheluck, AS; Lecuru, M; Lemaire, B; Mammeri, H; Plassart, C | 1 |
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Fattouh, R; McGeer, A; Melano, RG; Patel, SN; Poutanen, SM; Tijet, N | 1 |
Berrio, I; Castro, B; Maldonado, N; Manjarrés, M; Robledo, C; Robledo, J | 1 |
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P | 1 |
Chung, HS; Lee, M; Yong, D | 1 |
Davis, SL; Grunwald, JL; Kenney, RM; Veve, MP; Wagner, JL | 1 |
Burgers, PC; Dekker, LJ; Goessens, WH; Kostzrewa, M; Luider, TM; Monteferrante, CG; Peer, M; Sparbier, K; Sultan, S; Ten Kate, MT | 1 |
Jitmuang, A; Kiratisin, P; Rattanaumpawan, P; Thamlikitkul, V; Werarak, P | 1 |
Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK | 1 |
Ashcroft, M; Weinbren, M | 1 |
Behera, B; Das, A; Kapil, A; Mathur, P | 1 |
Bennett, JW; Herrera, ML; Jorgensen, JH; Lewis, JS; Mende, K; Murray, CK; Wickes, BL; Yu, X | 1 |
Salman, S; Van Sickels, JE; Young, M | 1 |
Ferraro, MJ; Hooper, DC; Hyle, EP; Lee, H; Silver, M | 1 |
Bolognesi, MP; Henderson, RA; Kaufman, AM; Watters, TS; Wellman, SS | 1 |
Hsu, MS; Hsueh, PR; Huang, YT; Liao, CH; Liu, CY; Yang, CJ | 1 |
Bayraktar, B; Dalgic, N; Dincer, E; Pelit, S; Sancar, M | 1 |
Agın, H; Devrim, I; Dizdarer, C; Gulfidan, G; Gunay, I; Güven, B; Yılmazer, MM | 1 |
Dihmess, A; Evans, A; Fiorenza, M; Graffunder, E; Harrington, S; Lodise, TP; Martis, P; Masoud, R; McNutt, LA; Patel, N; Woo, B | 1 |
Chen, CP; Chen, TL; Fung, CP; Lee, YT; Siu, LK | 1 |
Hung, KH; Wu, JJ; Yan, JJ; Yang, FC | 1 |
Abreu-Lanfranco, O; Bhargava, P; Bheemreddy, S; Blunden, C; Carmeli, Y; Chopra, T; Chugh, N; Collins, VL; Eiseler, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Memon, BI; Moshos, J; Munoz-Price, LS; Pogue, JM; Shallal, A; Sunkara, B | 1 |
Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J | 1 |
Hsueh, PR | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Ho, MW; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
Chanawong, A; Charoensri, N; Chetchotisakd, P; Kerdsin, A; Lulitanond, A; Phumsrikaew, W; Rimrang, B; Sribenjalux, P; Wilailuckana, C; Wonglakorn, L | 1 |
Autenrieth, IB; Gröbner, S; Marschal, M; Pfeifer, Y; Weissgerber, P; Wienke, M | 1 |
Koh, TH; Krishnan, PU; Lim, TP; Lye, D; Marimuthu, K; Ng, TM; Tan, TY; Teng, C | 1 |
Bartizal, K; Friedland, I; Motyl, M; Pelak, BA; Teppler, H; Woods, GL | 1 |
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL | 1 |
Alhambra, A; Alós, JI; Cacho, J; Cuadros, JA; Gómez-Garcés, JL | 1 |
Ferguson, EC; Matthias, KR; Nix, DE | 1 |
Chryssouli, Z; Galani, I; Giamarellou, H; Orlandou, K; Souli, M | 1 |
Chuang, YM; Ho, YC; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV | 1 |
Alos, JI; Cacho, J; Cuadros, J; Gomez-Garces, JL; Orden, B; Tamayo, J | 1 |
5 trial(s) available for ertapenem and Cronobacter Infections
Article | Year |
---|---|
Is the subcutaneous route an alternative for administering ertapenem to older patients? PHACINERTA study.
Topics: Administration, Intravenous; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Enterobacteriaceae Infections; Ertapenem; Female; France; Geriatrics; Humans; Injections, Subcutaneous; Male; Monte Carlo Method; Prospective Studies | 2019 |
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome | 2016 |
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2017 |
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2003 |
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities | 2006 |
77 other study(ies) available for ertapenem and Cronobacter Infections
Article | Year |
---|---|
Extended-spectrum beta-lactamases of the CTX-M type now in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Prevalence; Switzerland | 2007 |
Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Health Surveys; Hospitals, Private; Molecular Sequence Data; Plasmids | 2007 |
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Latin America; Microbial Sensitivity Tests; Minocycline; North America; Population Surveillance; Tigecycline | 2008 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype | 2010 |
Spread of OXA-48-encoding plasmid in Turkey and beyond.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids; Turkey | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence | 2010 |
Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Citrobacter freundii; Enterobacteriaceae Infections; Female; Humans; India; Molecular Sequence Data; Young Adult | 2011 |
[Enterobacter cancerogenus bacteremia in a patient with pelvic trauma].
Topics: Adult; Bacteremia; Chile; Enterobacter; Enterobacteriaceae Infections; Ertapenem; Humans; Male | 2022 |
Modification and evaluation of the Triton Hodge test for screening carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Octoxynol; Sensitivity and Specificity | 2019 |
Personalized Ertapenem Prophylaxis for Carriers of Extended-spectrum β-Lactamase-producing Enterobacteriaceae Undergoing Colorectal Surgery.
Topics: Anti-Bacterial Agents; beta-Lactamases; Colorectal Surgery; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Israel; Prospective Studies; Switzerland | 2020 |
Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial R
Topics: Amikacin; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pacific Islands; Population Surveillance | 2020 |
In Vitro Efficacy of Meropenem-Cefmetazole Combination Therapy against New Delhi Metallo-β-lactamase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefmetazole; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem | 2020 |
The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefuroxime; Cephalosporins; Colorectal Surgery; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Metronidazole; Spectroscopy, Fourier Transform Infrared | 2021 |
A Tail Fiber Engineering Platform for Improved Bacterial Transduction-Based Diagnostic Reagents.
Topics: Anti-Bacterial Agents; Bacteriophage P1; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Genetic Engineering; Microbial Sensitivity Tests; Phenotype; Synthetic Biology; Transduction, Genetic; Viral Tail Proteins | 2021 |
Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamases; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Outpatients; Quality Improvement; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2021 |
Carbapenemase-Producing Enterobacteriaceae Isolates from Edo State, Nigeria.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Cefotaxime; Ceftazidime; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Ertapenem; Fluoroquinolones; Humans; Nigeria; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2017 |
A Triple-Disk Enrichment Method for Carbapenem-Resistant Enterobacteriaceae (CRE) Screening.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fluconazole; Humans; Linezolid; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2017 |
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
From Dusk to Dawn: Understanding the Impact of Ertapenem Resistance Mechanisms on the In Vitro Potency of Other Drugs Among Enterobacter cloacae Complex Isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenem-Resistant Enterobacteriaceae; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Humans; Infection Control; Microbial Sensitivity Tests | 2018 |
Effect of Carbapenem Selection on Drug Acquisition Costs and Carbapenem Resistance.
Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States | 2019 |
Activity of Ertapenem against Enterobacteriaceae in seven global regions-SMART 2012-2016.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans | 2018 |
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult | 2018 |
Antimicrobial susceptibility of ertapenem-non-susceptible Enterobacteriaceae in South India.
Topics: Anti-Bacterial Agents; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; India; Microbial Sensitivity Tests; Prospective Studies | 2018 |
[Clinical impact of ertapenem de-escalation in critically-ill patients with Enterobacteriaceae infections].
Topics: Adult; Aged; Anti-Bacterial Agents; Colombia; Critical Illness; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Pseudomonas; Risk Factors; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2019 |
Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Enterobacter; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Retrospective Studies; Treatment Outcome | 2019 |
Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactam Resistance; Cefazolin; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Retrospective Studies | 2019 |
Topics: Aged, 80 and over; Anti-Bacterial Agents; Arthritis, Gouty; Citrobacter koseri; Debridement; Diabetic Foot; Enterobacteriaceae Infections; Ertapenem; Humans; Male; Osteomyelitis; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2019 |
Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Female; Gram-Negative Bacteria; Humans; Imipenem; Inpatients; Male; United States; Urinary Tract Infections | 2013 |
Assessment of extended-spectrum β-lactamase, KPC carbapenemase and porin resistance mechanisms in clinical samples of Klebsiella pneumoniae and Enterobacter spp.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Porins | 2013 |
Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Disinfection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genes, Bacterial; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan; Ureteroscopes; Urinary Tract Infections | 2013 |
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 2014 |
Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cefotaxime; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests | 2014 |
Heteroresistance to carbapenems in New Delhi metallo-β-lactamase-1-producing isolates: a challenge for detection?
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disease Susceptibility; Drug Resistance, Multiple; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Providencia; Thienamycins | 2014 |
Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Pennsylvania; Plasmids; Young Adult | 2014 |
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2014 |
Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Taiwan; Thienamycins | 2015 |
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hypoalbuminemia; Israel; Middle Aged; Prospective Studies; Risk Factors | 2015 |
Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals, University; Humans; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity; Tertiary Care Centers | 2015 |
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins | 2015 |
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Ceftazidime; Dipeptides; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; France; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence; Prospective Studies | 2016 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
What Is the Appropriate Meropenem MIC for Screening of Carbapenemase-Producing Enterobacteriaceae in Low-Prevalence Settings?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacter; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella; Meropenem; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Thienamycins | 2015 |
Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors.
Topics: Aged; Antimicrobial Stewardship; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cefepime; Colombia; Cross Infection; Diagnosis-Related Groups; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2017 |
Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital.
Topics: Aged; Aged, 80 and over; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitals, University; Humans; Infant; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Tertiary Care Centers | 2016 |
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Male; Middle Aged; Outpatients; Patient Readmission; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clinical Laboratory Techniques; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: results from the Study for Monitoring Antimicrobial Resistance Tr
Topics: Anti-Bacterial Agents; Asia; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Pacific Islands; Urinary Tract Infections | 2017 |
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests | 2009 |
Ertapenem resistance and the Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem | 2009 |
Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals; Humans; India; Microbial Sensitivity Tests | 2009 |
Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.
Topics: Anti-Infective Agents; beta-Lactams; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Imipenem; Longitudinal Studies; Microbial Sensitivity Tests; Population Surveillance | 2010 |
Mechanisms of carbapenem resistance among a collection of Enterobacteriaceae clinical isolates in a Texas city.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Plasmids; Texas | 2010 |
Osteomyelitis after bilateral sagittal split osteotomy: case report and a review of the management.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Bone Plates; Bone Screws; Clindamycin; Drainage; Enterobacteriaceae Infections; Ertapenem; Female; Gram-Negative Bacterial Infections; Humans; Jaw Fixation Techniques; Mandible; Ofloxacin; Open Bite; Orthognathic Surgical Procedures; Osteomyelitis; Osteotomy; Osteotomy, Le Fort; Retrognathia; Streptococcal Infections | 2011 |
Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Boston; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Ertapenem; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome; Urban Population; Young Adult | 2010 |
Citrobacter koseri as a cause of early periprosthetic infection after primary total hip arthroplasty.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; beta-Lactams; Citrobacter koseri; Debridement; Enterobacteriaceae Infections; Ertapenem; Hip Joint; Hip Prosthesis; Humans; Joint Diseases; Male; Middle Aged; Prosthesis-Related Infections; Radiography; Therapeutic Irrigation; Treatment Outcome | 2011 |
In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Quinolones; Tigecycline | 2011 |
Ertapenem for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria in children.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Follow-Up Studies; Hospitals; Humans; Infant; Male; Pyelonephritis; Recurrence; Retrospective Studies; Turkey; Urinary Tract Infections | 2011 |
Comparison of in vitro activity of ertapenem with other carbapenems against extended-spectrum beta-lactamase-producing Escherichia coli and Kleibsella species isolated in a tertiary children's hospital.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Child; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, University; Humans; Klebsiella; Microbial Sensitivity Tests | 2011 |
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Case-Control Studies; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Meropenem; Middle Aged; Risk Factors; Thienamycins | 2011 |
Impact of derepressed AmpC beta-lactamase ACT-9 on the clinical efficacy of ertapenem.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Enterobacteriaceae Infections; Ertapenem; Humans; Male; Molecular Sequence Data; Mutation; N-Acetylmuramoyl-L-alanine Amidase; Pantoea | 2011 |
Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cluster Analysis; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Gene Expression Profiling; Genotype; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Typing; Reverse Transcriptase Polymerase Chain Reaction; Taiwan | 2012 |
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2012 |
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult | 2012 |
Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010.
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans; Microbial Sensitivity Tests | 2012 |
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Linear Models; Meropenem; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Taiwan; Thienamycins | 2012 |
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies | 2012 |
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Thailand | 2012 |
In vitro activity of tigecycline and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from a university hospital in south-western Germany.
Topics: beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Germany; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Prevalence; Retrospective Studies; Tigecycline | 2012 |
Risk factors and treatment outcome of ertapenem non-susceptible enterobacteriaceae bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Thienamycins; Treatment Outcome | 2013 |
Comparative in-vitro activities of ertapenem against aerobic bacterial pathogens isolated from patients with complicated intra-abdominal infections.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests | 2002 |
In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Genes, Bacterial; Humans; Lactams; Microbial Sensitivity Tests; Urinary Tract Infections | 2004 |
Effect of ertapenem protein binding on killing of bacteria.
Topics: Bacteria; beta-Lactams; Chromatography, High Pressure Liquid; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Humans; Indicators and Reagents; Kinetics; Lactams; Microbial Sensitivity Tests; Protein Binding; Regression Analysis; Spectrophotometry, Ultraviolet; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Characterization of a new integron containing bla(VIM-1) and aac(6')-IIc in an Enterobacter cloacae clinical isolate from Greece.
Topics: Acetyltransferases; Aged; Amino Acid Sequence; Bacteremia; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Greece; Humans; Imipenem; Integrons; Lactams; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction | 2005 |
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries | 2006 |
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Topics: Adult; Anti-Bacterial Agents; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Spain; Urine | 2007 |